480 related articles for article (PubMed ID: 17576940)
41. The differential diagnosis of erythema nodosum.
O'Neill JH
Del Med J; 1991 Nov; 63(11):683-9. PubMed ID: 1786841
[TBL] [Abstract][Full Text] [Related]
42. Allergic reactions to 6-mercaptopurine during treatment of inflammatory bowel disease.
Korelitz BI; Zlatanic J; Goel F; Fuller S
J Clin Gastroenterol; 1999 Jun; 28(4):341-4. PubMed ID: 10372932
[TBL] [Abstract][Full Text] [Related]
43. Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine.
Seksik P; Cosnes J; Sokol H; Nion-Larmurier I; Gendre JP; Beaugerie L
Aliment Pharmacol Ther; 2009 May; 29(10):1106-13. PubMed ID: 19222411
[TBL] [Abstract][Full Text] [Related]
44. Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease.
Marion JF
Inflamm Bowel Dis; 1998 May; 4(2):116-7. PubMed ID: 9687219
[No Abstract] [Full Text] [Related]
45. Erythema nodosum.
Requena L; Requena C
Dermatol Online J; 2002 Jun; 8(1):4. PubMed ID: 12165214
[TBL] [Abstract][Full Text] [Related]
46. Azathioprine hypersensitivity presenting as a neutrophilic dermatosis in a man with ulcerative colitis.
Yiasemides E; Thom G
Australas J Dermatol; 2009 Feb; 50(1):48-51. PubMed ID: 19178493
[TBL] [Abstract][Full Text] [Related]
47. Azathioprine in controlling type 2 reactions in leprosy: a case report.
Athreya SP
Lepr Rev; 2007 Sep; 78(3):290-2. PubMed ID: 18035780
[No Abstract] [Full Text] [Related]
48. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.
Ansari A; Arenas M; Greenfield SM; Morris D; Lindsay J; Gilshenan K; Smith M; Lewis C; Marinaki A; Duley J; Sanderson J
Aliment Pharmacol Ther; 2008 Oct; 28(8):973-83. PubMed ID: 18616518
[TBL] [Abstract][Full Text] [Related]
49. Erythema nodosum.
Passarini B; Infusino SD
G Ital Dermatol Venereol; 2013 Aug; 148(4):413-7. PubMed ID: 23900162
[TBL] [Abstract][Full Text] [Related]
50. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
[TBL] [Abstract][Full Text] [Related]
51. The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.
Kim DU; Kim YH; Kim BJ; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC
Hepatogastroenterology; 2009; 56(94-95):1395-402. PubMed ID: 19950798
[TBL] [Abstract][Full Text] [Related]
52. Azathioprine formulation optimizes metabolite profile in inflammatory bowel disease.
Stevens T; Achkar JP; Easley K; Brzezinski A; Lashner B
Aliment Pharmacol Ther; 2004 Sep; 20(6):601-6. PubMed ID: 15352907
[TBL] [Abstract][Full Text] [Related]
53. Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease.
Xin H; Fischer C; Schwab M; Klotz U
Aliment Pharmacol Ther; 2005 May; 21(9):1105-9. PubMed ID: 15854172
[TBL] [Abstract][Full Text] [Related]
54. [Erythema nodosum in the clinical picture of internal diseases].
Tareev EM; Kornev BM; Moiseev SV
Ter Arkh; 1986; 58(6):36-9. PubMed ID: 3764712
[TBL] [Abstract][Full Text] [Related]
55. Cutaneous manifestations of systemic disease.
Cahill J; Sinclair R
Aust Fam Physician; 2005 May; 34(5):335-40. PubMed ID: 15887934
[TBL] [Abstract][Full Text] [Related]
56. Azathioprine side effects in the treatment of chronic inflammatory bowel disease.
González Lara V; Pérez Calle JL
Rev Esp Enferm Dig; 2001 Dec; 93(12):765-8. PubMed ID: 11995358
[No Abstract] [Full Text] [Related]
57. Acute pancreatitis and erythema nodosum associated with azathioprine.
Lai SW; Wang YC; Wang CH; Huang TY
QJM; 2012 Apr; 105(4):363-4. PubMed ID: 21398663
[No Abstract] [Full Text] [Related]
58. Hypersensitivity reaction to azathioprine.
Fields CL; Robinson JW; Roy TM; Ossorio MA; Byrd RP
South Med J; 1998 May; 91(5):471-4. PubMed ID: 9598858
[TBL] [Abstract][Full Text] [Related]
59. A triangulation study of the clinician and patient experiences of the use of the immunosuppressant drugs azathioprine and 6-mercaptopurine for the management of inflammatory bowel disease.
Holbrook K
J Clin Nurs; 2007 Aug; 16(8):1427-34. PubMed ID: 17655530
[TBL] [Abstract][Full Text] [Related]
60. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
Bermejo F; Lopez-Sanroman A; Taxonera C; Gisbert JP; Pérez-Calle JL; Vera I; Menchén L; Martín-Arranz MD; Opio V; Carneros JA; Van-Domselaar M; Mendoza JL; Luna M; López P; Calvo M; Algaba A
Aliment Pharmacol Ther; 2008 Sep; 28(5):623-8. PubMed ID: 18513380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
